Literature DB >> 21942233

Some supplementary methods for the analysis of the RBANS.

John R Crawford1, Paul H Garthwaite, Nicola Morrice, Kevin Duff.   

Abstract

Supplementary methods for the analysis of the Repeatable Battery for the Assessment of Neuropsychological Status are made available, including (a) quantifying the number of abnormally low Index scores and abnormally large differences exhibited by a case and accompanying this with estimates of the percentages of the normative population expected to exhibit at least this number of low scores and large differences, (b) estimating the overall abnormality of a case's Index score profile using the Mahalanobis Distance Index (MDI), (c) reporting confidence limits on differences between a case's Index scores, and (d) offering the option of applying a sequential Bonferroni correction when testing for reliable differences. With the exception of the MDI, all the methods can be obtained using the formulas and tables provided in this article. However, for the convenience of clinicians, and to reduce the possibility of clerical error, the methods have also been implemented in a computer program. More importantly, the program allows the methods to be applied when only a subset of the Indexes is available. The program can be downloaded from www.abdn.ac.uk/~psy086/dept/RBANS_Supplementary_Analysis.htm (c) 2012 APA, all rights reserved

Entities:  

Mesh:

Year:  2011        PMID: 21942233     DOI: 10.1037/a0025652

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  2 in total

1.  RBANS Validity Indices: a Systematic Review and Meta-Analysis.

Authors:  Robert D Shura; Timothy W Brearly; Jared A Rowland; Sarah L Martindale; Holly M Miskey; Kevin Duff
Journal:  Neuropsychol Rev       Date:  2018-05-16       Impact factor: 7.444

2.  Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue.

Authors:  Sanne Menning; Michiel B de Ruiter; Dick J Veltman; V Koppelmans; Clemens Kirschbaum; Willem Boogerd; Liesbeth Reneman; Sanne B Schagen
Journal:  Neuroimage Clin       Date:  2015-02-20       Impact factor: 4.881

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.